ORIGINAL RESEARCH article
Front. Endocrinol.
Sec. Gut Endocrinology
Volume 16 - 2025 | doi: 10.3389/fendo.2025.1508473
This article is part of the Research TopicThe Mechanism in Gut Microbiota of Diabetes and Endocrine Complications: Preventive and Therapeutic TargetView all 11 articles
Animal studies on the modulation of differential efficacy of polyethylene glycol loxenatide by intestinal flora
Provisionally accepted
Wenjiao Dang Wenjiao Dang
Wang Yurou Wang
Xie Jiaqi Xie
He Yan He
Ji Hongfang JiChen Min ChenGuo Jianjin Guo*- Shanxi Bethune Hospital, Shanxi Medical University, Taiyuan, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background:Gut microbiota has demonstrated an increasingly important role in the onset and development of type 2 diabetes mellitus (T2DM), Further investigations have revealed the interactions between drugs and the gut microbiome. However, there are still gaps in research regarding the potential interactions between the gut microbiota and GLP-1 and their therapeutic response in people with T2DM. In addition, Fecal microbiota transplantation (FMT) has become a promising strategy for patients with T2DM.
Keywords: type 2 diabetes, intestinal flora, GLP-1 receptor agonists, polyethylene glycol exenatide, fecal microbiota transplantation, 16S rDNA
Received: 09 Oct 2024; Accepted: 24 Mar 2025.
Copyright: © 2025 Wenjiao Dang, Wang, Xie, He, Ji, Chen and Guo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Guo Jianjin Guo, Shanxi Bethune Hospital, Shanxi Medical University, Taiyuan, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.